Comparison of Beck Depression Score in Multipar and Nulliparous Women Who Have Gone Under Dilatation and Curettage


It is aimed to compare the beck depression and anxiety values of the nulliparous and multiparous pregnant women who undergo optional abortion below 12 weeks, and to evaluate the effect of the parity on depression and anxiety.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 10, 2019

Detailed Description

The beck depression and anxiety scale consists of questionnaire questions asked to the patient, and the value on 17 indicates advanced depression.

The BDI inventory has maximum of 63 and minimum of 0 scores:

(0-10): Are considered normal ups and downs (11-16): Mild mood disturbance (17-20): Borderline clinical depression (21-30): Moderate depression, (31-40): Severe depression, Over 40: Extreme depression. A persistent score of !17, requires psychiatric treatment

Arms, Groups and Cohorts

  • Nullipar pregnant women
  • multipar pregnant women

Clinical Trial Outcome Measures

Primary Measures

  • Comparison of Beck Depression and Anxiety Scores in Multipar and Nulliparous Women who have gone under Dilatation and Curettage
    • Time Frame: 3 months
    • to evaluate the effect of the parity on depression and anxiety.

Participating in This Clinical Trial

Inclusion Criteria

  • healthy
  • Women with a pregnancy less than 12 weeks
  • no psychiatric disease or drug use

Exclusion Criteria

  • Those who have had a psychiatric diagnosis before,
  • Women under the age of 18,
  • Psychiatric drug users,
  • Those who have experienced a major trauma or disease
  • During the 3-month follow-up period, who developed complications during the procedure pregnant again
  • Women with a pregnancy greater than 12 weeks

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Kanuni Sultan Suleyman Training and Research Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Pınar Yalcin bahat, Principal Investigator – Kanuni Sultan Suleyman Training and Research Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.